ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Pulmonary Disease

Top Pulmonary Disease Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAMESH KAUL MD, FCCP, MS

Pulmonary Disease

11,481

$1.28M

833
590 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 66%

$112
Average prescription price

Avg: $213

RICHARD SAUNDERS M.D.

Pulmonary Disease

9,227

$593K

563
380 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 66%

$64
Average prescription price

Avg: $213

JOHN SOLIC

Pulmonary Disease

7,859

$747K

616
534 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 66%

$95
Average prescription price

Avg: $213

RUDOLF KHUSID M.D.

Pulmonary Disease

7,655

$1.38M

470
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 66%

$180
Average prescription price

Avg: $213

WILLIAM FEE MD

Pulmonary Disease

6,557

$383K

505
427 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 66%

$58
Average prescription price

Avg: $213

VIRGINIA BALDERSTON M.D.

Pulmonary Disease

5,997

$444K

566
510 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 66%

$74
Average prescription price

Avg: $213

GARY ESPER D.O.

Pulmonary Disease

5,201

$537K

344
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 66%

$103
Average prescription price

Avg: $213

EDWARD THEURKAUF MD

Pulmonary Disease

4,801

$193K

209
206 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 66%

$40
Average prescription price

Avg: $213

BRIAN BURLEW MD

Pulmonary Disease

4,246

$537K

486
409 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 66%

$126
Average prescription price

Avg: $213

ROBERT JOHNSON MD

Pulmonary Disease

4,178

$332K

335
281 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 66%

$79
Average prescription price

Avg: $213

JEFFREY RATNER MD

Pulmonary Disease

4,099

$465K

278
223 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 66%

$113
Average prescription price

Avg: $213

JOHN COX M.D.

Pulmonary Disease

4,052

$503K

397
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 66%

$124
Average prescription price

Avg: $213

DAVID CELKO M.D.

Pulmonary Disease

3,575

$595K

433
361 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 66%

$166
Average prescription price

Avg: $213

MICHAEL ADER M.D.

Pulmonary Disease

3,530

$691K

376
292 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 66%

$196
Average prescription price

Avg: $213

HOWARD LEE M.D.

Pulmonary Disease

3,335

$862K

329
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 66%

$259
Average prescription price

Avg: $213

RICHARD HALE D.O.

Pulmonary Disease

3,032

$243K

319
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 66%

$80
Average prescription price

Avg: $213

YUSUF KHAN MD

Pulmonary Disease

2,956

$757K

258
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 66%

$256
Average prescription price

Avg: $213

GREGORY CALI D.O.

Pulmonary Disease

2,950

$991K

351
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 66%

$336
Average prescription price

Avg: $213

RAHAT CHAUDHRY M.D.

Pulmonary Disease

2,931

$367K

279
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 66%

$125
Average prescription price

Avg: $213

PHILIP CAREY MD

Pulmonary Disease

2,757

$355K

239
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 66%

$129
Average prescription price

Avg: $213

PATRICK STURM M.D.

Pulmonary Disease

2,605

$509K

354
278 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 66%

$195
Average prescription price

Avg: $213

KENNETH LANDER M.D.

Pulmonary Disease

2,582

$456K

233
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 66%

$177
Average prescription price

Avg: $213

RICHARD SHUSTERMAN M.D.

Pulmonary Disease

2,577

$733K

336
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 66%

$284
Average prescription price

Avg: $213

KENNEDY SBAT DO

Pulmonary Disease

2,572

$681K

416
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 66%

$265
Average prescription price

Avg: $213

GREGORY PATRICK MD

Pulmonary Disease

2,549

$373K

313
269 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 66%

$147
Average prescription price

Avg: $213

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank